Explore actionable strategies, real-world examples, and how sponsors, CROs, and technology providers can make sustainability a priority in clinical
Kayentis partners with clinical trial technology providers, industry bodies, patient communities, and language specialists to improve the clinical trial experience for sites and patients, and to ensure the data collected is high-quality, interoperable, and audit-ready.
Clinical trials run on multiple connected systems. Kayentis integrates with leading IRT, EDC, CTMS, and wearable platforms to streamline data flow, reduce manual reconciliation, and improve data quality across your trial technology stack.
Kayentis also partners with rater training service provider to better address complex clinical trials, such as neuroscience.
Our partnerships range from improving the site and patient experience to enabling deep, bidirectional data integration.
We are an active member of the eCOA Consortium hosted by C-Path. The consortium brings together eCOA technology providers and service partners to advance standards, research, and best practices for the electronic collection of COA and DHT data in clinical trials.
Our involvement ensures Kayentis solutions stay ahead of evolving regulatory and methodological expectations.
Recent publications in collaboration with the eCOA Consortium
In clinical trials, especially those involving participants unable to self-report—such as children or individuals with cognitive impairments—caregiver-reported data is
The eCOA: Getting Better Together Initiative launched by the Critical Path Institute in 2019 aimed to identify and address
The best eCOA solutions start with the patient’s lived experience. We work directly with patients, caregivers, and site communities to gain a clear understanding of their day-to-day realities, reduce burden, improve comprehension, and design experiences that support engagement and high-quality data for clinical outcomes.
Discover patient insights
What rare disease patients and families want is a simpler life.Discover here what makes the relationship between the members
Patient-facing content must be linguistically validated, ready for ethics committee review, and delivered on time. Supporting 120+ languages, we partner with specialized Language Service Providers (LSPs) to support questionnaire translation, cultural adaptation, licensing, and electronic implementation validation, streamlining the path from study setup to certified deliverables.
Schedule a 15-minute call to explore integration options for your trial. Tell us what you need, and we’ll get back to you with a recommendation.
More patient insights
What rare disease patients and families want is a simpler life.Discover here what makes the relationship between the members
